International Journal of Pediatric Health Care & Advancements (IJPA)    IJPA-2572-7354-04-601

A Case of Infant Malignant Lymphoma that Healed Completely after Oral Administrations of 4-Hydroxybenzaldehyde


Okazaki K*

Okazaki Medical Clinic, Ukyoku, Kyoto Japan.


*Corresponding Author

Kimihiko Okazaki,
Okazaki Medical Clinic, Ukyoku, Kyoto, Japan.
E-mail: ma13081x@ma1.seikyou.ne.jp

Received: September 29, 2017; Accepted: October 11, 2017; Published: October 13, 2017

Citation: Okazaki K. A Case of Infant Malignant Lymphoma that Healed Completely after Oral Administrations of 4-Hydroxybenzaldehyde. Int J Pediat Health Care Adv. 2017;4(6):54. doi: dx.doi.org/10.19070/2572-7354-1700015

Copyright: Okazaki K© 2017. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.


In 1985, Mutsuyuki Kochi [1, 2] reported a novel anti-tumor agent after acquiring a Japanese Patent in 1969. According to his patent, 4-Hydroxybenzaldehyde is an anti-tumor agent without any sideeffects. My impression is that this stuff is capable of preventing carcinogenesis when used quantitatively sufficiently. In order to treat developed cancers, you ought to start giving your cancer patient a small dose of the stuff because, otherwise, the patient may suffer from a serious hemorrhage of the tumor caused by excessive necroses. Therefore, lymphomas and leukemias can be treated more easily because these tumors have no blood vessels. Consequently, those who have these diseases can receive considerably large dose of the stuff.

A 2-year-old girl (R.I.) was diagnosed to have a cervical malignant lymphoma with diameter of 50mm at a local Cancer Center on November 1, 2012. Her parent demanded me to prescribe her with 4-Hydroxybenzaldehyde on November 12, 2012. I prescribed daily 333mg of 4-Hydroxybenzaldehyde as an aqueous solution of 500mg % for her on November 16, 2012. I raised the doses to daily 500mg in February, 2013, in early summer of 2013, the tumor disappeared. As of September 27, 2017, she is enjoying a healthy life.



References

  1. Kochi M. Antitumor activity of benzaldehyde derivative. Cancer Treat Rep. 1985 May;69(5):533-537. PubMed PMID: 4005876. https://www.ncbi. nlm.nih.gov/pubmed/4005876
  2. Kochi M. Manufacturing Process of Anticancer Substance. Japanese Patent, No.560349; 1969.


         Indexed in

               

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


Creative Commons License
SciDoc Publishers is licensed under a Creative Commons Attribution 4.0 International License.